Tiziana Life Sciences Plc
(NASDAQ: TLSA)
|
5:30 PM UTC, 07/03/24 | |||
---|---|---|---|---|
Last: $0.82 | Change: -0.03 | %Change: -3.96% | Volume: 109,467 |
Open: | $ 0.90 | Volume: | 109,467 | |
---|---|---|---|---|
High: | $ 0.90 | Yield(%) | 0.00 | |
Low: | $ 0.82 | P/E Ratio (ttm): | n/a | |
Dividend ($): | 0.02 | Market Cap ($): | 167.37M | |
EPS ($) | n/a | Shares Out: | 194.61M |
% Price Change (last 4 weeks): | -14.10 |
---|---|
% Price Change (last 13 weeks): | 90.04 |
% Price Change (last 26 weeks): | 50.69 |
% Price Change (last 52 weeks): | 24.58 |
% Price Change (year to date): | 53.57 |
Return on Equity (%): | -50.61 |
---|---|
Return on Assets (%): | -40.89 |
Return on Invested Capital (%): | -61.91 |
Gross Profit Margin (%): | n/a |
---|---|
Net Profit Margin (%): | n/a |
Operating Profit Margin (%): | 0.00 |
|
|
50-day Moving Average: | $0.81 |
---|---|
200-day Moving Average: | $0.63 |
Avg. Daily Vol. (last 50 days): | 278,105 |
Avg. Daily Vol. (last 200 days): | 139,910 |
52-wk high: | $1.05 |
52-wk low: | $0.41 |
Bid: | $0.80 |
Ask: | $0.97 |
Tiziana Life Sciences Ltd. is a clinical-stage biotechnology company, which engages in the research and development of biotechnological and pharmaceutical products. It specializes in developing transformative therapies for neurodegenerative and lung diseases. The company was founded by Gabriele Marco Antonio Cerrone on February 11, 1998 and is headquartered in London, the United Kingdom.
|
Tiziana Life Sciences Plc
14/15 Conduit Street London GL W1S 2XJ Phone: 44.207.495.2379 Fax: n/a http://www.tizianalifesciences.com |
Earnings (1year) ($): | -0.15 |
---|---|
Annual Dividend ($): | 0.00 |
Current P/E Ratio (ttm): | n/a |
Book Value ($): | 0.19 |
Cash Flow ($): | -0.15 |
Price/Earnings (x): | n/a |
---|---|
Price/Sales (x): | n/a |
Price/Book (x): | 3.08 |
Price/Cash Flow (x): | n/a |
Quick Ratio (x): | 3.64 |
---|---|
Current Ratio (x): | 3.64 |
LT Debt/Equity (x): | 1.24 |
Total Debt/Equity (x): | 1.87 |